Published in Dig Dis Sci on August 17, 2007
Systematic review of animal models of post-infectious/post-inflammatory irritable bowel syndrome. J Gastroenterol (2010) 1.14
NMDA Receptors and Colitis: Basic Science and Clinical Implications. Rev Analg (2008) 0.91
Neurological and cellular regulation of visceral hypersensitivity induced by chronic stress and colonic inflammation in rats. Neuroscience (2013) 0.89
Localized colonic stem cell transplantation enhances tissue regeneration in murine colitis. J Cell Mol Med (2012) 0.88
Host immune response determines visceral hyperalgesia in a rat model of post-inflammatory irritable bowel syndrome. J Gastroenterol (2013) 0.79
Visceral Hypersensitivity Is Provoked by 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Ileitis in Rats. Front Pharmacol (2016) 0.77
A novel model for studying ileitis-induced visceral hypersensitivity in goats. Acta Vet Scand (2016) 0.75
Altered sympathovagal balance and pain hypersensitivity in TNBS-induced colitis. Arch Med Sci (2016) 0.75
Visceral hypersensitive rats share common dysbiosis features with irritable bowel syndrome patients. World J Gastroenterol (2016) 0.75
Moxibustion eases chronic inflammatory visceral pain through regulating MEK, ERK and CREB in rats. World J Gastroenterol (2017) 0.75
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain (1988) 18.17
Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology (1989) 7.59
Basic and clinical aspects of visceral hyperalgesia. Gastroenterology (1994) 4.39
A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology (2000) 3.31
Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut (1997) 2.77
Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology (1990) 2.75
Visceral pain: a review of experimental studies. Pain (1990) 2.47
Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the rat. Brain Res (1988) 2.44
Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome. Gastroenterology (1995) 2.29
Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain (2000) 1.97
A new model of visceral pain and referred hyperalgesia in the mouse. Pain (2001) 1.97
Visceral pain. Lancet (1999) 1.88
Organization of the sacral parasympathetic reflex pathways to the urinary bladder and large intestine. J Auton Nerv Syst (1981) 1.88
A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders. Gastroenterology (2005) 1.77
Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients. Pain (2003) 1.74
Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain (2001) 1.71
Characterization of cyclophosphamide cystitis, a model of visceral and referred pain, in the mouse: species and strain differences. J Urol (2003) 1.37
Cross-organ sensitization of lumbosacral spinal neurons receiving urinary bladder input in rats with inflamed colon. Gastroenterology (2005) 1.32
A model for the study of visceral pain states: chronic inflammation of the chronic decerebrate rat urinary bladder by irritant chemicals. Pain (1987) 1.32
Pregabalin (CI-1008) inhibits the trinitrobenzene sulfonic acid-induced chronic colonic allodynia in the rat. J Pharmacol Exp Ther (2002) 1.25
Recent and forgotten aspects of visceral pain. Eur J Pain (1999) 1.24
Visceral hypersensitivity and altered colonic motility after subsidence of inflammation in a rat model of colitis. World J Gastroenterol (2003) 1.24
Prolonged colonic epithelial hyporesponsiveness after colitis: role of inducible nitric oxide synthase. Am J Physiol (1999) 1.21
Uterine inflammation as a noxious visceral stimulus: behavioral characterization in the rat. Neurosci Lett (1998) 1.16
Effects of kappa opioids in the inflamed rat colon. Pain (1999) 1.15
Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism. Dig Dis Sci (1995) 1.15
Inflammation of the rat urinary bladder is associated with a referred thermal hyperalgesia which is nerve growth factor dependent. Br J Anaesth (1999) 1.15
Perceptual responses in patients with inflammatory and functional bowel disease. Gut (2000) 1.13
On the function of spinal primary afferent fibres supplying colon and urinary bladder. J Auton Nerv Syst (1990) 1.07
Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder. Anesthesiology (2001) 1.05
Visceral and cutaneous hypersensitivity in Persian Gulf war veterans with chronic gastrointestinal symptoms. Pain (2003) 1.05
Acute colitis induction by oil of mustard results in later development of an IBS-like accelerated upper GI transit in mice. Am J Physiol Gastrointest Liver Physiol (2005) 1.04
Short-chain fatty acid enemas fail to decrease colonic hypersensitivity and inflammation in TNBS-induced colonic inflammation in rats. Pain (2002) 1.02
Selective up-regulation of NMDA-NR1 receptor expression in myenteric plexus after TNBS induced colitis in rats. Mol Pain (2006) 0.98
Interactions between visceral and cutaneous nociception in the rat. II. Noxious visceral stimuli inhibit cutaneous nociceptive neurons and reflexes. J Neurophysiol (1991) 0.98
Postsynaptic dorsal column neurons express NK1 receptors following colon inflammation. Neuroscience (2003) 0.93
Persistent and selective effects of inflammation on smooth muscle cell contractility in rat colitis. Pflugers Arch (2004) 0.93
Disruption of the blood-brain barrier during TNBS colitis. Neurogastroenterol Motil (2005) 0.89
Inhibition of a cutaneous nociceptive reflex by a noxious visceral stimulus is mediated by spinal cholinergic and descending serotonergic systems in the rat. Brain Res (1992) 0.86
Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat. J Pharmacol Exp Ther (2000) 0.83
The capsaicin analogue SDZ249-665 attenuates the hyper-reflexia and referred hyperalgesia associated with inflammation of the rat urinary bladder. Pain (2001) 0.83
Intestinal anti-nociceptive behaviour of NK3 receptor antagonism in conscious rats: evidence to support a peripheral mechanism of action. Neurogastroenterol Motil (2003) 0.82
Pre-emptive analgesia in rats with artificial ureteric calculosis. Effects on visceral pain behavior in the post-operative period. Brain Res (2000) 0.81
Azithromycin and erythromycin ameliorate the extent of colonic damage induced by acetic acid in rats. Toxicol Appl Pharmacol (2004) 0.81
Colonic inflammation decreases thermal sensitivity of the forepaw and hindpaw in the rat. Neurosci Lett (2004) 0.78
Inhibition of withdrawal responses by pelvic nerve electrical stimulation. Brain Res (1995) 0.77
Colorectal distension-induced suppression of a nociceptive somatic reflex response in the rat: modulation by tissue injury or inflammation. Brain Res (2004) 0.77
A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain (2002) 3.17
Peripheral and central contributions to hyperalgesia in irritable bowel syndrome. J Pain (2006) 2.65
Racial/ethnic differences in the experience of chronic pain. Pain (2002) 2.40
MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. Gut (2009) 2.39
The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain (2003) 2.33
A randomized clinical trial of a brief hypnosis intervention to control side effects in breast surgery patients. J Natl Cancer Inst (2007) 2.18
Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain (2006) 2.09
Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors. Pain (2008) 1.98
Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain (2003) 1.89
Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome. Pain (2003) 1.87
Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain (2009) 1.80
Individual differences in pain sensitivity: genetic and environmental contributions. Pain (2007) 1.77
Pain measurement and brain activity: will neuroimages replace pain ratings? J Pain (2013) 1.76
Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients. Pain (2003) 1.74
Gender role expectations of pain: relationship to experimental pain perception. Pain (2002) 1.56
Spatial summation of mechanically evoked muscle pain and painful aftersensations in normal subjects and fibromyalgia patients. Pain (2007) 1.56
Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. Pain (2009) 1.55
Placebo-induced analgesia in an operant pain model in rats. Pain (2012) 1.55
Influences of gender role and anxiety on sex differences in temporal summation of pain. J Pain (2004) 1.55
Use of a novel thermal operant behavioral assay for characterization of orofacial pain sensitivity. Pain (2005) 1.53
Temporal summation of second pain and its maintenance are useful for characterizing widespread central sensitization of fibromyalgia patients. J Pain (2007) 1.51
Receptor for advanced glycation end product (RAGE) upregulation in human gingival fibroblasts incubated with nornicotine. J Periodontol (2005) 1.48
Functional brain interactions that serve cognitive-affective processing during pain and placebo analgesia. Neuroimage (2007) 1.48
Morphine responses and experimental pain: sex differences in side effects and cardiovascular responses but not analgesia. J Pain (2005) 1.47
Individual differences in pain sensitivity: measurement, causation, and consequences. J Pain (2009) 1.45
Ratings of experimental pain and pain-related negative affect predict clinical pain in patients with fibromyalgia syndrome. Pain (2003) 1.44
Isometric exercise has opposite effects on central pain mechanisms in fibromyalgia patients compared to normal controls. Pain (2005) 1.40
Do hypnotic analgesic interventions contain placebo effects? Pain (2006) 1.39
Brain activity related to temporal summation of C-fiber evoked pain. Pain (2006) 1.36
Maintenance of windup of second pain requires less frequent stimulation in fibromyalgia patients compared to normal controls. Pain (2004) 1.33
Visual analog scales for assessing surgical pain. J Am Coll Surg (2005) 1.32
Brain activity associated with slow temporal summation of C-fiber evoked pain in fibromyalgia patients and healthy controls. Eur J Pain (2008) 1.32
Visceral and somatic hypersensitivity in a subset of rats following TNBS-induced colitis. Pain (2007) 1.30
Cutaneous C-fiber pain abnormalities of fibromyalgia patients are specifically related to temporal summation. Pain (2008) 1.22
The dynamic mechanisms of placebo induced analgesia: Evidence of sustained and transient regional involvement. Pain (2008) 1.21
Body pain area and pain-related negative affect predict clinical pain intensity in patients with fibromyalgia. J Pain (2004) 1.21
Effects of the N-methyl-D-aspartate receptor antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal control subjects. J Pain (2005) 1.19
Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007. Pain (2009) 1.18
Characterization of cold sensitivity and thermal preference using an operant orofacial assay. Mol Pain (2006) 1.17
Widespread hyperalgesia in irritable bowel syndrome is dynamically maintained by tonic visceral impulse input and placebo/nocebo factors: evidence from human psychophysics, animal models, and neuroimaging. Neuroimage (2009) 1.17
Central and peripheral hypersensitivity in the irritable bowel syndrome. Pain (2010) 1.15
Advanced continuous-contact heat pulse design for efficient temporal summation of second pain (windup). J Pain (2006) 1.13
Revelation of a personal placebo response: its effects on mood, attitudes and future placebo responding. Pain (2007) 1.10
Intrarectal lidocaine is an effective treatment for abdominal pain associated with diarrhea-predominant irritable bowel syndrome. J Pain (2005) 1.08
Characterization of mouse orofacial pain and the effects of lesioning TRPV1-expressing neurons on operant behavior. Mol Pain (2008) 1.08
Experimental pain models reveal no sex differences in pentazocine analgesia in humans. Anesthesiology (2004) 1.07
Altering gender role expectations: effects on pain tolerance, pain threshold, and pain ratings. J Pain (2003) 1.07
Megacolon and stercoral proctitis after frequent fecal impactions: report of an unusual case and review of the literature. J Am Med Dir Assoc (2007) 1.07
Hypnosis modulates activity in brain structures involved in the regulation of consciousness. J Cogn Neurosci (2002) 1.06
Characterizing individual differences in heat-pain sensitivity. Pain (2005) 1.06
Differentiation between capsaicin-induced allodynia and hyperalgesia using a thermal operant assay. Behav Brain Res (2006) 1.05
Visceral and cutaneous hypersensitivity in Persian Gulf war veterans with chronic gastrointestinal symptoms. Pain (2003) 1.05
Reversal of visceral and somatic hypersensitivity in a subset of hypersensitive rats by intracolonic lidocaine. Pain (2008) 1.05
Gray matter volumes of pain-related brain areas are decreased in fibromyalgia syndrome. J Pain (2010) 1.04
Irritable bowel syndrome as a common precipitant of central sensitization. Curr Rheumatol Rep (2002) 1.04
Thermal and visceral hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia. Clin J Pain (2007) 1.03
Pain variability in fibromyalgia is related to activity and rest: role of peripheral tissue impulse input. J Pain (2010) 0.99
Patient-centered perspective on treatment outcomes in chronic pain. Pain Med (2009) 0.99
Evidence for autonomic dysregulation in the irritable bowel syndrome. Dig Dis Sci (2002) 0.98
Adaptation of a novel operant orofacial testing system to characterize both mechanical and thermal pain. Behav Brain Res (2010) 0.98
Selective up-regulation of NMDA-NR1 receptor expression in myenteric plexus after TNBS induced colitis in rats. Mol Pain (2006) 0.98
Peripheral targeting of the trigeminal ganglion via the infraorbital foramen as a therapeutic strategy. Brain Res Brain Res Protoc (2005) 0.98
Effects of the N-methyl-D-aspartate receptor on temporal summation of second pain (wind-up) in irritable bowel syndrome. J Pain (2010) 0.96
New solutions to an old problem: acute colonic pseudo-obstruction. J Clin Gastroenterol (2005) 0.96
Plasticity in brain processing and modulation of pain. Prog Brain Res (2006) 0.96
miRNA-based therapies for the irritable bowel syndrome. Expert Opin Biol Ther (2011) 0.95
Spinal NMDA NR1 subunit expression following transient TNBS colitis. Brain Res (2009) 0.95
Two novel mutations of SCN9A (Nav1.7) are associated with partial congenital insensitivity to pain. Eur J Pain (2010) 0.95
Reduction of conditioned pain modulation in humans by naltrexone: an exploratory study of the effects of pain catastrophizing. J Behav Med (2012) 0.94
Mechanical and heat hyperalgesia highly predict clinical pain intensity in patients with chronic musculoskeletal pain syndromes. J Pain (2012) 0.93
New insights into visceral hypersensitivity--clinical implications in IBS. Nat Rev Gastroenterol Hepatol (2011) 0.92
Spatial summation of heat pain within and across dermatomes in fibromyalgia patients and pain-free subjects. Pain (2004) 0.90
Use of the Operant Orofacial Pain Assessment Device (OPAD) to measure changes in nociceptive behavior. J Vis Exp (2013) 0.89
Localized colonic stem cell transplantation enhances tissue regeneration in murine colitis. J Cell Mol Med (2012) 0.88
Phosphorylation of NMDA NR1 subunits in the myenteric plexus during TNBS induced colitis. Neurosci Lett (2006) 0.88
Effect of caloric and non-caloric sweet reward solutions on thermal facial operant conditioning. Behav Brain Res (2010) 0.87
Patients' direct experiences as central elements of placebo analgesia. Philos Trans R Soc Lond B Biol Sci (2011) 0.87
What is controlled for in placebo-controlled trials? Mayo Clin Proc (2005) 0.87
Prevalence of gastroparesis in patients with small duct chronic pancreatitis. Pancreas (2003) 0.87